Skip to main content

Table 4 Clinical studies on high-flow nasal oxygen (HFNO) therapy in adults with hypoxemic acute respiratory failure (ARF) [44–46]

From: High-flow nasal oxygen vs. standard oxygen therapy in immunocompromised patients with acute respiratory failure: study protocol for a randomized controlled trial

Reference

Study design

Population

N patients

Results

Hypoxemic acute respiratory failure in the ICU

[22]

Cohort, unselected patients. HFNO 50 L/min vs. face-mask oxygen

Hypoxemic ARF

38

Improved oxygenation

Decreased respiratory rate

[23]

Cohort, unselected patients. HFNO 20–30 L/min vs. face-mask oxygen

Hypoxemic ARF

20

Improved oxygenation

Decreases in respiratory/heart rates, dyspnea, respiratory distress, and thoraco-abdominal asynchrony

[47]

HFNO compared to face-mask oxygen

Hypoxemic ARF

60

Decreased treatment failure (defined as need for NIV) from 30% to 10%. Fewer desaturation episodes

[48]

Cohort study. HFNO 20–30 L/min vs. face-mask oxygen

Hypoxemic ARF

20

Improved comfort; improved oxygenation

[49]

Cohort study (post hoc)

Hypoxemic ARF (2009 A/H1N1v outbreak)

20

9/20 (45%) success (no intubation). All 8 patients on vasopressors required intubation within 24 h. After 6 h of HFNO, non-responders had lower PaO2/FiO2 values and needed higher oxygen flow rates.

[43]

Observational, single-centre study

ARDS

45

40% intubation rate. HFNO failure associated with higher SAPSII, development of additional organ failure, and trends toward lower PaO2/FiO2 values and higher respiratory rates

[13]

Multicentre, open-label RCT with 3 groups. HFNO, usual oxygen therapy (face mask), or non-invasive positive-pressure ventilation

Hypoxemic ARF, PaO2/FiO2 ≤ 300

310

Intubation rate was 38% with HFNO, 47% with standard oxygen, and 50% with NIV. The number of ventilator-free days by day 28 was significantly higher with HFNO. Decreased day-90 mortality with HFNO

[50]

Retrospective before/after study of HFNO

Hypoxemic ARF

172

Reduced need for ventilation (100% vs 63%, p < 0.01) and decreased ventilator-free days

[42]

Patients intubated after HFNO

Hypoxemic ARF

175

In patients intubated early, lower mortality (39.2 vs. 66.7%), higher extubation success (37.7% vs. 15.6%) and more ventilator-free days. Early intubation was associated with decreased ICU mortality

Hypoxemic acute respiratory failure in the ED

[51]

Patients with ARF (> 9 L/min oxygen or clinical signs of respiratory distress)

Hypoxemic ARF

17

Decreased dyspnea and respiratory rate and improved oxygenation

[52]

RCT of HFNO vs. standard oxygen for 1 h

Hypoxemic ARF

40

Decreased dyspnea and improved comfort

  1. ARDS acute respiratory distress syndrome, ICU intensive care unit, NIV non-invasive ventilation, RCT randomized controlled trial